Inventor · disambiguated record
Mark W. Dewhirst
Also filed as: DEWHIRST MARK · DEWHIRST MARK W · DEWHIRST MARK WESLEY
40 granted patents·18 pending applications·408 citations·filing 1987–2024
98Inventor score
Top patents by PatentIndex Score
58 records- 0193US9023249B2Adhesive bonding composition and method of useFATHI ZAKARYAE·Filed 2011·Granted May 5, 2015·23 cites·17 claims
- 0293US6472390B1Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressureUNIV DUKE·Filed 2001·Granted Oct 29, 2002·65 cites·27 claims
- 0392US7338670B2Use of an agent that restores tissue perfusion and oxygenationUNIV DUKE·Filed 2006·Granted Mar 4, 2008·16 cites·10 claims
- 0489US10596387B2Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic propertiesIMMUNOLIGHT LLC·Filed 2015·Granted Mar 24, 2020·13 cites·108 claims
- 0589US9907976B2Phosphors and scintillators for light stimulation within a mediumBOURKE JR FREDERIC A·Filed 2012·Granted Mar 6, 2018·25 cites·104 claims
- 0689US7769423B2MRI imageable liposomes for the evaluation of treatment efficacy, thermal distribution, and demonstration of dose paintingUNIV DUKE·Filed 2006·Granted Aug 3, 2010·21 cites·54 claims
- 0788US11786595B2Methods for radiotherapy to trigger light activation drugsIMMUNOLIGHT LLC·Filed 2021·Granted Oct 17, 2023·1 cites·52 claims
- 0888US9232618B2Up and down conversion systems for production of emitted light from various energy sources including radio frequency, microwave energy and magnetic induction sources for upconversionBOURKE JR FREDERIC A·Filed 2010·Granted Jan 5, 2016·9 cites·135 claims
- 0987US11207409B2X-RAY psoralen activated cancer therapy (X-PACT) with associated treatmentsIMMUNOLIGHT LLC·Filed 2018·Granted Dec 28, 2021·3 cites·32 claims
- 1087US10232190B2Phosphors and scintillators for light stimulation within a mediumIMMUNOLIGHT LLC·Filed 2017·Granted Mar 19, 2019·6 cites·50 claims
- 1187US9649832B2Adhesive bonding composition and method of useIMMUNOLIGHT LLC·Filed 2015·Granted May 16, 2017·4 cites·33 claims
- 1287US7208138B2Contrast enhancement agent for magnetic resonance imagingYEDA RES & DEV·Filed 2005·Granted Apr 24, 2007·5 cites·16 claims
- 1385US6972122B2Contrast enhancement agent for magnetic resonance imagingYEDA RES & DEV·Filed 2001·Granted Dec 6, 2005·19 cites·15 claims
- 1484US11865359B2Tumor imaging with x-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic propertiesIMMUNOLIGHT LLC·Filed 2019·Granted Jan 9, 2024·1 cites·97 claims
- 1582US11571587B2Method for treating a disease, disorder, or condition using inhalation to administer an activatable pharmaceutical agent, an energy modulation agent, or bothIMMUNOLIGHT LLC·Filed 2020·Granted Feb 7, 2023·1 cites·51 claims
- 1681US11305131B2X-ray psoralen activated cancer therapy (X-PACT)IMMUNOLIGHT LLC·Filed 2019·Granted Apr 19, 2022·1 cites·37 claims
- 1780US7790204B2Use of an agent that restores tissue perfusion and oxygenationUNIV DUKE·Filed 2008·Granted Sep 7, 2010·2 cites·11 claims
- 1880US7183262B2Method for selective expression of therapeutic genes by hyperthermiaUNIV DUKE·Filed 2002·Granted Feb 27, 2007·9 cites·17 claims
- 1980US5554638AMethods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disordersUNIV DUKE·Filed 1994·Granted Sep 10, 1996·48 cites·24 claims
- 2079US8466110B2Use of an agent that restores tissue perfusion and oxygenationDEWHIRST MARK W·Filed 2012·Granted Jun 18, 2013·3 cites·17 claims
- 2179US7795219B2Use of an agent that restores tissue perfusion and oxygenationUNIV DUKE·Filed 2008·Granted Sep 14, 2010·2 cites·5 claims
- 2278US11285162B2Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposureBIOMIMETIX JV LLC·Filed 2018·Granted Mar 29, 2022·2 cites·52 claims
- 2376US2025041314A1Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposureBIOMIMETIX JV LLC·Filed 2024·Application pending·0 cites
- 2475US10709900B2Phosphors and scintillators for light stimulation within a mediumIMMUNOLIGHT LLC·Filed 2019·Granted Jul 14, 2020·1 cites·18 claims
- 2575US8198241B2Use of an agent that restores tissue perfusion and oxygenationDEWHIRST MARK W·Filed 2010·Granted Jun 12, 2012·2 cites·5 claims
- 2674US10441810B2X-ray psoralen activated cancer therapy (X-PACT)IMMUNOLIGHT LLC·Filed 2017·Granted Oct 15, 2019·3 cites·41 claims
- 2774US10253367B1Biomarkers for locally advanced breast cancer (LABC) and inflammatory breast cancer (IBC)UNIV DUKE·Filed 2014·Granted Apr 9, 2019·2 cites·8 claims
- 2874US2024042233A1Tumor imaging with x-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic propertiesIMMUNOLIGHT LLC·Filed 2023·Application pending·0 cites
- 2972US12171769B2Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposureBIOMIMETIX JV LLC·Filed 2022·Granted Dec 24, 2024·0 cites·22 claims
- 3071US11135294B2Methods for radiotherapy to trigger light activation drugsIMMUNOLIGHT LLC·Filed 2016·Granted Oct 5, 2021·1 cites·100 claims
- 3167US11992697B2X-ray psoralen activated cancer therapy (X-PACT)IMMUNOLIGHT LLC·Filed 2022·Granted May 28, 2024·0 cites·35 claims
- 3265US8946289B2Manassatin compounds and methods of making and using the sameHONG JIYONG·Filed 2009·Granted Feb 3, 2015·4 cites·23 claims
- 3364US9056080B2Use of an agent that restores tissue perfusion and oxygenationUNIV DUKE·Filed 2013·Granted Jun 16, 2015·0 cites·10 claims
- 3462US5612310AMethods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disordersUNIV DUKE·Filed 1993·Granted Mar 18, 1997·27 cites·19 claims
- 3560US4753248AProbe translation system for use in hyperthermia treatmentUNIV DUKE·Filed 1987·Granted Jun 28, 1988·70 cites·23 claims
- 3659US7672704B2Methods and compositions for blood pool identification, drug distribution quantification and drug release verificationUNIV DUKE·Filed 2003·Granted Mar 2, 2010·10 cites·26 claims
- 3758US2010203024A1Sickled Erythrocytes, Nucleated Precursors & Erythroleukemia Cells for Targeted Delivery of Oncolytic Viruses, Anti-tumor Proteins, Plasmids, Toxins, Hemolysins & ChemotherapyTERMAN DAVID S·Filed 2007·Application pending·0 cites
- 3855US2007135373A1Method for selective expression of therapeutic genes by hyperthermiaUNIV DUKE·Filed 2006·Application pending·0 cites
- 3953US2006099709A1Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumorsLI CHUAN-YUAN·Filed 2003·Application pending·0 cites
- 4052US2004151666A1Rodent mammary window for intravital microscopy of orthotopic breast cancer and related methodUNIV DUKE·Filed 2003·Application pending·0 cites
- 4151US8968702B2Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responsesLI CHUAN-YUAN·Filed 2007·Granted Mar 3, 2015·0 cites·6 claims
- 4249US9771620B2Biomarkers of high-grade serous ovarian carcinomasUNIV DUKE·Filed 2014·Granted Sep 26, 2017·0 cites·4 claims
- 4347US2007218551A1Novel Sirna-Based Approach to Target the Hif-Alpha Factor for Gene TherapyLI CHUAN-YUAN·Filed 2004·Application pending·0 cites
- 4446US2013023587A1Compositions and methods for the treatment of cancerUNIV DUKE·Filed 2011·Application pending·0 cites
- 4546US2010151576A1Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumorsLI CHUAN-YUAN·Filed 2010·Application pending·0 cites
- 4645US6020308AMethods for improving therapeutic effectiveness of treatment of vascularization disordersUNIV DUKE·Filed 1998·Granted Feb 1, 2000·4 cites·8 claims
- 4745US2014249097A1Inhibition of HIF-1 activation for Anti-Tumor and Anti-Inflammatory responsesDEWHIRST MARK W·Filed 2011·Application pending·0 cites
- 4844US2011287110A1Combination cancer treatmentDEWHIRST MARK WESLEY·Filed 2011·Application pending·0 cites
- 4943US5788958AMethods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disordersUNIV DUKE·Filed 1996·Granted Aug 4, 1998·5 cites·6 claims
- 5043US2011110866A1Elastin-like polypeptide and gadolinium conjugate for magnetic resonance imagingUNIV DUKE·Filed 2008·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →